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PURPOSE. A role for a bacterium, Bacillus oleronius, originally isolated from a Demodex mite,
in the induction of ocular rosacea has been proposed. The aim of this work was to
characterize the response of a corneal epithelial cell line to Bacillus proteins, as this might
give an insight into how such proteins contribute to the symptoms of ocular rosacea in vivo.
METHODS. The effect of exposing Bacillus protein preparation on human telomerase-
immortalized corneal epithelial cells (hTCEpi) was measured by monitoring changes in cell
proliferation and the expression of a number of genes associated with inflammation. The
production of inflammatory cytokines was measured and the expression and activity of MMP-
9 was quantified.
RESULTS. Exposure of hTCEpi cells to 2 or 6 lg/mL Bacillus protein resulted in a dose-
dependent reduction in cell proliferation. Exposure of cells to 6 lg/mL Bacillus protein did
not induce apoptosis, but there was an increase in the expression of genes coding for IL-6
(13.8-fold), IL-1b (4.0-fold), IL-8 (11.1-fold), and TNF-a (4.1-fold). Increased expression of
genes coding for the defensins, CCL20 (4.5-fold) and S100A7 (6.8-fold) also was observed.
Elevated production of IL-6 and IL-8 was evident from cells exposed to 2 and 6 lg/mL Bacillus
protein. The hTCEpi cells demonstrated increased MMP-9 expression (3.2-fold, P ¼ 0.003)
and activity (2.2-fold, P ¼ 0.0186) after 48 hours of exposure to 6 lg/mL Bacillus protein
preparation.
CONCLUSIONS. The results suggest that interaction of Demodex-associated Bacillus proteins
with the corneal surface could lead to tissue degradation and inflammation, possibly leading
to corneal scarring.
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Rosacea is a chronic inflammatory dermatological conditionthat predominantly affects the skin of the face and the
eyes.1,2 It is estimated that the condition affects approximately
3% of the population and there are at least 14 million sufferers
in the United States. A number of forms of rosacea are
recognized, including papulopustular, erythematotelangiec-
tatic, ocular, and phymatous.3 Ocular rosacea affects the eyes
and the eyelids, causing symptoms such as blepharitis and
keratitis, and up to half of those diagnosed with facial rosacea
also manifest ocular symptoms.4,5 Corneal (sterile) ulcers and
corneal scarring are associated with severe cases of ocular
rosacea and can lead to a deterioration in vision and potentially
blindness in affected eyes.6 Although the classification of
rosacea is now well established, there is no agreement on its
etiology. A number of factors have been implicated in the
induction and persistence of rosacea, including alterations in
the immune response, increased dermal vascularization, and
the presence of reactive oxygen species in the skin.7
Patients affected with rosacea display a higher density of
facial mites, Demodex folliculorum, than unaffected con-
trols,8–11 although the significance of this observation has
never been fully explained. Elevated numbers of Demodex
mites also are present on the eyelashes of patients with ocular
rosacea.12
A potential role for bacteria in the induction of rosacea has
been suggested, because antibiotics (e.g., erythromycin,
metronidazole) can be used to treat the condition, although
these may also exhibit anti-inflammatory properties.2,13 Staph-
ylococcus epidermidis isolated from rosacea patients were
consistently b-hemolytic and grew better at 378C than 308C,
suggesting a potential link between mesophilic hydrolytic
bacteria and rosacea.14 This bacterium also has been isolated
from the pustules of patients with papulopustular rosacea and
from the eyelids of patients with ocular rosacea, suggesting a
possible role for this bacterium in the induction of these
conditions.15 A bacterium (Bacillus oleronius), originally
isolated from a Demodex folliculorum mite from a patient
with papulopustular rosacea, produced proteins that induced
an inflammatory immune response in 72% of rosacea patients
but only 29% of controls (P ¼ 0.01).16 This bacterium also has
been isolated from the eyelashes of patients with blepharitis17
and is sensitive to the antibiotics used to treat rosacea.16 A
strong correlation has been established between ocular
Demodex inflammation and serum reactivity to these bacterial
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proteins in patients with ocular rosacea.12 In addition, the
presence of eyelid margin inflammation (P ¼ 0.04) and facial
rosacea (P ¼ 0.009) correlated with reactivity to these
proteins.12 Neutrophils exposed to Bacillus proteins demon-
strated increased migration and elevated release of MMP-9, an
enzyme known to degrade collagen, and cathelicidin, an
antimicrobial peptide. Exposure of neutrophils to the bacterial
proteins resulted in elevated production of IL-8 and TNF-a.18
Increased production of IL-8 is a trigger for neutrophil
recruitment to the site of infection, and TNF-a is indicative of
an inflammatory response. These studies suggest a possible
role for bacterial proteins in the etiology of rosacea.12,16,18
Human telomerase-immortalized corneal epithelial cells
(hTCEpi) are an excellent model for studying the response of
the corneal surface to pathogens or pathogen-derived materials
(e.g., toxins, antigens) and may give an insight into the
response of the cornea to bacterial interactions in ocular
rosacea. Human telomerase-immortalized corneal epithelial
cells have previously been used to study the interaction of
flagellin from pathogenic and nonpathogenic bacteria,19 and in
understanding the response of the corneal surface to the
combined effect of contact lens and Pseudomonas aerugino-
sa.20
In a previous study, we characterized the response of the
hTCEpi cells to Bacillus proteins in terms of alterations in cell
migration and invasiveness.21 The results indicated increased
cell migration and invasiveness after exposure of the cells to
the Bacillus proteins. Cells exposed to Bacillus proteins
showed a dose-dependent increased expression of genes
coding for matrix metalloproteinase-3 (MMP-3) (61-fold) and
MMP-9 (300-fold). This dose-dependent increase in gene
expression also was reflected in elevated levels of MMP-9
protein and increased MMP activity in the culture supernatant.
These results suggest a possible link between exposure to
Bacillus proteins and the development of corneal damage in
ocular rosacea patients. The aim of present work was to
characterize whether exposure of hTCEpi cells to the Bacillus
proteins induced an inflammatory response, as this might give
an indication as to how these bacterial proteins induce the
erythema that is a feature of ocular rosacea.4,5 The complete
elucidation of the role of these proteins in inducing the
symptoms of ocular rosacea could open the possibility of
developing new therapeutic strategies for the control of this
disfiguring condition.
MATERIALS AND METHODS
Preparation of Bacterial Proteins
Cultures of B. oleronius were grown at 308C in nutrient broth
(Oxoid, Ltd.; Thermo Fisher Scientific, Inc., Waltham, MA,
USA) under aerobic conditions to stationary phase of growth
before protein extractions were performed as described.16 This
protein fraction was termed ‘‘crude B. oleronius protein’’ and
was diluted to a working concentration of 200 lg/mL in PBS
(pH 7.4). The B. oleronius protein extract was purified by
anion exchange separation using fast protein liquid chroma-
tography (FPLC) using an A¨KTA Purifier 100 system (A¨KTA
FPLC; GE Healthcare, Little Chalfont, UK) as described.18 The
‘‘crude B. oleronius protein’’ extract was incubated at 48C
overnight in Q-Sepharose beads (Q Sepharose High Perfor-
mance; GE Healthcare) and binding buffer (20 mM piperazine,
10 mM NaCl in dH2O, pH 4.6). Fractionation by Q-Sepharose
charge separation of the crude B. oleronius protein extract to
the semipurified B. oleronius protein preparation was
performed by increasing the concentration of a salt gradient
using elution buffer (20 mM piperazine, 1 M NaCl in dH2O, pH
4.6). The fractions separated from the A¨KTA FPLC column of
interest were pooled and precipitated. The semipurified
protein preparation was visualized by 1D SDS-PAGE staining
with Coomassie blue as a quality assurance of the Q-Sepharose
A¨KTA FPLC separation process and maintained at a concentra-
tion of 200 lg/mL in PBS (termed as ‘‘pure’’ protein in Figs. 1–
8).
Cell Culture
Human telomerase-immortalized corneal epithelial cells were
maintained in keratinocyte growth medium (KGM)-2 supple-
mented with KGM-2 SingleQuot Kit Supplements and Growth
Factors (Lonza, Basel, Switzerland), in a 5% CO2 humidified
atmosphere incubator at 378C, and passaged every 3 to 5 days.
Cells were left to adhere overnight before stimulants were
added to the media: crude B. oleronius protein preparation (2
lg/mL) or semipurified B. oleronius protein preparation (2 lg/
mL and 6 lg/mL).
Corneal Cell Proliferation
Human telomerase-immortalized corneal epithelial cells were
seeded into a 6-well culture plate (Corning Life Sciences,
Corning, NY, USA) at a density of 5 3 105 cells per well,
allowed to attach, and exposed to semipurified B. oleronius
proteins at concentrations of 2 and 6 lg/mL. Cell counts were
performed on days 0, 1, 2, 3, and 6 using a hemocytometer
(Neubauer improved Hemocytometer; Marienfeld-Superior
Ltd., Lauda-Ko¨nigshofen, Germany) and cell viability was
measured using the trypan blue exclusion method. Human
telomerase-immortalized corneal epithelial cells were co-
cultured with the Bacillus proteins for the duration of the
assay.
Cell Cycle Analysis
Human telomerase-immortalized corneal epithelial cells were
seeded into 6-well plates (Corning) at a density of 13 104 cells
per well. Cells attached during a 2-hour incubation and were
then treated using KGM-Gold media (Lonza) alone or KGM-
Gold media supplemented with 6 lg/mL ‘‘pure’’ B. oleronius
proteins. After 48 hours of exposure, cells were harvested
using 0.25% trypsin/0.022% EDTA, washed with PBS, and fixed
with ice-cold 90% methanol (Sigma-Aldrich Corp., St. Louis,
MO, USA). Samples were stained using propidium iodide
(Biotium, Inc., Hayward, CA, USA) according to the manufac-
turer’s instructions and analyzed using a Guava easyCyte HT
flow cytometer (Millipore, Billerica, MA, USA). The percentag-
es of cells in Gap-1 (G1), Synthesis (S), and Gap-2 (G2) phases
of the cell cycle were calculated using the ModFit LT 3.2 DNA
cell-cycle analysis software (Verity Software House, Topsham,
ME, USA).
Caspase-3 and Caspase-7 Immunofluorescence
Assay
Human telomerase-immortalized corneal epithelial cells were
cultured for 3 days in culture dishes (CELLVIEW, cell culture
dish with glass bottom, TC, 35 mm, 1 compartment; Greiner
Bio-one GMbH, Frickenhausen, Germany) (2 3 105 cells per
well) under the following conditions: untreated, dimethyl
sulfoxide (DMSO) (1%, vol/vol), and purified B. oleronius
protein (6 lg/mL) before fixing and staining for caspase-3/7
activity and assessed following the guidelines in the Image-iT
LIVE Red Caspase-3 and -7 Detection Kit (Invitrogen, Du´n
Laoghaire Co., Dublin, Ireland). Cells were stained with
fluorescent-labeled inhibitor of caspases (FLICA) reagent that
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becomes covalently and irreversibly coupled to active caspase-
3/7 (excitation/emission at 550/595 nm), and Hoescht 33342
(a nuclear stain with excitation/emission at 350/461 nm) was
used to visualize hTCEpi cells positive and negative for caspase-
3/7. Results represent experiments performed in triplicate and
determined for five fields of view per treatment for each repeat
of the assay. Images were captured on a Nikon TiE microscope
(Nikon UK Limited, Kinston upon Thames, Surrey, UK)
controlled and analyzed using MetaMorph software (Molecular
Devices, Marlow, Buckinghamshire, UK).
RNA Extraction and Gene Expression Analysis
Human telomerase-immortalized corneal epithelial cells (6 3
104/well) were seeded in 6-well culture dishes and exposed to
semipurified B. oleronius proteins (0, 2, or 6 lg/mL) for 5 days,
with feeding and treatment on alternate days. Following PBS
washes (33), tri-reagent (1 mL/well) was applied and RNA
extracted according to manufacturer’s instructions (Sigma-
Aldrich). RNA concentration was determined using a Nano-
Drop spectrophotometer (ND-1000; Labtech International,
East Sussex, England) and cDNA synthesized using a high-
capacity RNA to cDNA kit (Applied Biosystems, Carlsbad, CA,
USA). Amplification of chemokine ligand-20 (CCL20), IL-1b, IL-
6, IL-8, S100A7, and TNF targets was performed using TaqMan
Gene Expression Assays (Hs01011368_m1, Hs01555410_m1,
Hs00985639_m1, Hs00174103_m1, Hs00161488_m1,
Hs00174128_m1, respectively) in conjunction with an ABI
7500 Fast Real-time PCR thermal cycler (Applied Biosystems,
Foster City, CA, USA).
Electrophoresis and Western Blots
Cell supernatants were collected from hTCEpi cells exposed to
semipurified B. oleronius protein (2 and 6 lg/mL) for 24, 48,
or 72 hours in culture conditions described above. Collected
samples were concentrated by centrifugation using 3000
MCWO Vivaspin-20 (Vivaproducts, Littleton, MA, USA) filter
columns, and protein (20 lg) was loaded onto a 10%
acrylamide gel and separated under reducing conditions. After
electrophoresis, resolved proteins were transferred onto a
nitrocellulose membrane (Fisher Scientific, Ballycoolin, Dublin,
Ireland), using a transfer rig in transfer buffer (25 mM Tris, 192
mM glycine, methanol [20%, vol/vol] in dH2O, pH 8.3).
Membranes were blocked using 1% (wt/vol) BSA in Tris-
buffered saline (TBS) (pH 7.6) with 0.05% (vol/vol) Tween-20
(Sigma-Aldrich) for 1 hour at room temperature. Primary
antibodies were diluted as follows: anti-CCL20 (raised in rabbit
[Abnova, Taipei City, Taiwan]) 1/500; anti-S100A7 (raised in
rabbit [Sigma-Aldrich]) 1/600; anti-MMP-9 (raised in rabbit
[Sigma-Aldrich]) 1/500; and incubated at 48C overnight.
An anti-human horseradish peroxidase (HRP)-linked sec-
ondary antibody (HRP-linked rabbit antisera at a dilution of 1/
1000) was applied and incubated at room temperature for 2
hours. Immunoreactive protein bands were visualized by
incubating the membranes for 10 minutes in 10 mg diamino-
benzidine tetrahydrochloride in 15 mL of 100 mmol/L Tris-HCl
(pH 7.6) containing 15 lL hydrogen peroxide (Sigma-Aldrich)
before washing in distilled water and drying. Immuno-bands
were quantified by densitometry using ImageJ software (http://
imagej.nih.gov/ij/; provided in the public domain by the
National Institutes of Health, Bethesda, MD, USA).
Enzyme-Linked Immunosorbent Assay
Human telomerase-immortalized corneal epithelial cells were
exposed to crude B. oleronius protein (2 lg/mL), or semi-
purified B. oleronius protein (2 lg/mL) for 24 hours or 72
hours and the supernatants were collected. Secretion levels of
IL-6 and IL-8 were measured using commercial ELISA kits (mini-
development ELISA kit; PeproTech, Rocky Hill, NJ, USA)
according to the manufacturer’s guidelines.
Gelatinase Zymograms for MMP-9 Activity
Cell supernatants collected from cell proliferation assays at
days 3 and 6 after exposure of hTCEpi cells to B. oleronius
semipurified protein extract at 2 and 6 lg/mL were concen-
trated by centrifugation using 3000 MCWO Vivaspin-20 (Viva-
products) filter columns and loaded onto Novex 10%
zymogram (gelatin) gels (Invitrogen). Following electrophore-
sis, gels were incubated in zymogram-renaturing buffer
(Invitrogen) for 30 minutes at room temperature, left at 378C
overnight in developing buffer (Invitrogen), and stained with
Colloidal Coomassie (Brilliant Blue G-Colloidal Concentrate,
Electrophoresis Reagent; Sigma-Aldrich) for 2 hours before de-
staining of gels in distilled water and recording of gel images.
Statistical Methods
Resultant cycle threshold (Ct) values from real-time PCR
expression analyses, were normalized against human glyceral-
dehyde 3-phosphate dehydrogenase endogenous control ex-
pression (Hs99999905_m1) and changes in expression
calculated using the relative quantification (RQ) ¼ 2DDCt
equation. All experiments were performed on three indepen-
dent occasions and results are presented as the mean 6 SE.
Statistical significance was assessed by the Student’s t-test using
GraphPad Prism version 5.00 for Mac OS X (GraphPad
Software, San Diego, CA, USA; www.graphpad.com). P values
less than 0.05 (*), less than 0.01 (**), or less than 0.001 (***)
were deemed statistically significant.
RESULTS
Effect of Bacillus Proteins on hTCEpi Cell
Proliferation
Exposure of hTCEpi cells to 2 or 6 lg/mL Bacillus protein
reduced the growth rate of cells over a 6-day period (Fig. 1). Cell
proliferation was reduced by 34% and 42% in those cultures that
FIGURE 1. Exposure of B. oleronius proteins reduces the rate of
hTCEpi cell proliferation. The MGT for hTCEpi cells during the log
phase of growth between day 2 and day 3 of exposure to Bacillus
proteins at 2 and 6 lg/mL was calculated to be 91 hours and 123 hours,
respectively, compared with 76 hours for untreated cells. The growth
of hTCEpi cells was reduced in the presence of B. oleronius in a dose-
dependent manner. *P < 0.05.
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were exposed to 2 and 6 lg/mL semipurified Bacillus protein,
respectively, compared with the total cell number in the
untreated controls after a 72-hour incubation period. The mean
generation time (MGT) for cells during the log phase of growth
between day 2 and day 3 of exposure to Bacillus proteins at 2
and 6 lg/mL was calculated to be 91 hours and 123 hours,
respectively, whereas it was 76 hours in the control. A
significant decrease in corneal epithelial cell growth was
observed at day 3 following exposure to semipurified Bacillus
protein (6 lg/mL) (P¼ 0.0185) and reduced growth of hTCEpi
cells following 6 days of exposure to 2 or 6 lg/mL semipurified
Bacillus protein relative to control hTCEpi cells was significant
(P¼ 0.0111 and P¼ 0.0133, respectively). During the course of
a 6-day exposure to the semipurified Bacillus protein at 2 and 6
lg/mL, a statistical difference in total cell number between the
two doses at each time point was not observed, but a dose-
dependent increase in the MGT at day 3 between the
semipurified Bacillus protein treatments at 2 and 6 lg/mL
was found to be statistically significant (P¼ 0.0427).
Effect of B. oleronius Protein Exposure on Cell
Cycle
Cell-cycle analysis was performed to determine the effect of
semipurified B. oleronius proteins (6 lg/mL) on hTCEpi
progression through the phases of the cell cycle. By comparing
the DNA content of untreated hTCEpi cells (Fig. 2A) and B.
oleronius protein-treated hTCEpi cells (Fig. 2B), it was
observed that exposure to B. oleronius proteins induced
significant G1 phase arrest (P ¼ 0.0015) by increasing the
percentage of hTCEpi cells in the G1 phase from 58.66% to
72.91% (Fig. 2C). Accordingly, the percentage of cells in the S
phase also decreased (from 39.13% to 25.61%), concurrent
with B. oleronius protein treatment (P ¼ 0.002) (Fig. 2C),
suggesting that B. oleronius protein exposure may reduce
hTCEpi proliferation by impeding progression from the G1
growth phase to the S (synthesis) phase of the cell cycle.
Exposure to Bacillus Proteins Does Not Induce
Apoptosis in hTCEpi Cells
The cleavage of caspases, a family of cysteine–aspartic acid–
specific proteases, represent a distinctive feature of early
apoptosis. The exposure of hTCEpi cells to 6 lg/mL
semipurified B. oleronius protein did not induce the
increased production of caspase-3 and -7. After a 72-hour
treatment period, the semipurified Bacillus protein prepa-
ration showed that 3.09% of corneal cells were positive for
the apoptotic markers caspase-3 and -7, compared with
3.16% of control cells. In contrast, 61.34% of corneal cells
exposed to DMSO (1%, vol/vol) were positive for these
markers (P < 0.0001) (Fig. 3). The noninduction of caspases
FIGURE 2. Effect of B. oleronius protein on hTCEpi cell cycle. Cell cycle characteristics of both untreated (A) and semipurified B. oleronius protein
(6 lg/mL)-treated (B) hTCEpi cells were assessed by DNA content analysis after 48 hours of incubation. B. oleronius semipurified protein-treated
cells demonstrate an increased proportion of cells in G1 phase and a decreased proportion of cells in the S phase relative to untreated controls (C)
indicating that exposure to semipurified B. oleronius protein inhibits transition from the G1 growth phase into the S phase. *P < 0.05, **P < 0.001.
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after exposure to semipurified B. oleronius protein prepa-
ration suggests that the effect on growth of hTCEpi cells is
antiproliferative rather than via the induction of apoptosis.
Gene Expression Changes Induced by B. oleronius
Antigen Exposure
To assess the effect of B. oleronius protein exposure on
hTCEpi gene expression, the expression of a number of
genes that are known to participate in proinflammatory,
immune-modulated, and defense-associated activities during
wound healing was assessed (Fig. 4). Immediately after
barrier disruption in a healthy wound, proinflammatory
cytokines, including IL-6, IL-8, IL-1b, and TNF, are released.
These cytokines function in the acute phase to stimulate
inflammation and attract immune cells to the site of injury;
however, if proinflammatory cytokines continue to be
secreted at elevated concentrations after the acute phase,
complications may result. The hTCEpi cells exposed to both
low (2 lg/mL) and high (6 lg/mL) concentrations of B.
oleronius protein resulted in significant overexpression of
proinflammatory cytokines IL-1b (3.6-fold, P ¼ 0.0027, and
3.0-fold, P ¼ 0.0083, respectively) and TNF (4.9-fold, P ¼
0.0019, and 5.1-fold, P ¼ 0.0014, respectively) relative to
untreated cells (Fig. 4). Interleukins are regulators of the
corneal response to injury, and IL-1b acts as a proinflamma-
tory mediator, stimulating stromal fibroblasts to secrete
chemokines and amplify inflammatory responses,22 whereas
TNF also plays important roles in corneal inflammation and
wound healing.23 The highest relative upregulation of
cytokine expressions assessed were those of IL-6 (11.6-fold,
P ¼ 0.0337) and IL-8 (7.8-fold, P ¼ 0.0378) after exposure of
cells to 6 lg/mL B. oleronius. Secreted IL-6 is known to be
elevated in chronic wounds and overproduction of IL-6
protein may lead to the development of autoimmune
inflammatory diseases.24,25 Elevated IL-8 has been observed
in wounds that display retarded healing and IL-8 may directly
contribute to this effect by inhibition of keratinocyte
replication.26 In the cornea, IL-8 overexpression also has
been associated with ulcer formation via chemoattraction of
macrophages and subsequent destruction of tissue.27 Al-
though not itself a cytokine, overexpression of CCL20 (2.8-
fold, P ¼ 0.0355) also was observed in cells exposed to B.
oleronius antigen (6 lg/mL). Chemokine ligand-20 affects
corneal wound healing indirectly by attraction of specialized
IL-22–secreting cd T cells, which induce an inflammatory
response.28 The antimicrobial peptide Psoriasin-coding gene
S100A7 displayed overexpression at both 2 lg/mL and 6 lg/
mL B. oleronius exposure (4.3-fold, P ¼ 0.0124, and 5.1-fold,
P ¼ 0.0022, respectively). This protein was first discovered
due to its oversecretion in inflammatory skin disease
psoriasis and is known to be present at the ocular surface
in both tear films and corneal epithelium; however,
associations with corneal disease are as yet undescribed.29
Effect of Bacillus Proteins on Expression of CCL20
and S100A7 in Cells
Human telomerase-immortalized corneal epithelial cells were
exposed to semipurified B. oleronius proteins (2 lg/mL and 6
lg/mL) for 24, 48, and 72 hours, as described, and Western
blots were performed to assess the effect on the expression of
the defensins, CCL20 and S100A7 (Figs. 5A, 5C, respectively).
The results revealed increased expression of CCL20 in corneal
cells exposed to semipurified B. oleronius proteins at 2 lg/mL
and 6 lg/mL, with a 2.1 (P ¼ 0.0323) and 2.9-fold increase,
respectively, relative to the control at 24 hours. An increase of
CCL20 expression was observed at 48 hours, with a 2.6 (P ¼
0.0057) and 3.9-fold (P¼0.0178) increase of CCL20 expression
after exposure to the 2 lg/mL and 6 lg/mL semipurified B.
oleronius protein preparations, respectively. At 72 hours,
CCL20 expression in corneal cells treated with 2 lg/mL and 6
lg/mL semipurified Bacillus proteins showed a 2.5-fold (P ¼
0.0024) and 4.1-fold (P ¼ 0.0129) increase, respectively,
compared with the control. A significant dose-dependent
response between the 2-lg/mL and 6-lg/mL semipurified
Bacillus protein concentrations for the expression of CCL20
was not observed at 24, 48, or 72 hours after stimulation (Fig.
5B). Similarly, an increase in the expression of S100A7 was
observed in hTCEpi cells exposed to semipurified B. oleronius
FIGURE 3. The hTCEpi cells exposed to B. oleronius protein
preparation do not exhibit caspase activation. The hTCEpi cells were
exposed to semipurified Bacillus proteins (6 lg/mL), DMSO (1%, vol/
vol), or untreated (PBS) for 3 days. Caspase-3 and -7 activity was
assessed by capturing immunofluorescence images followed by
analysis through MetaMorph software. Results represent experiments
performed in triplicate and determined using five fields of view per
treatment for each repeat of the assay. ***P < 0.0001.
FIGURE 4. Effect of B. oleronius protein extract on gene expression in
hTCEpi cells. The effect of semipurified B. oleronius protein exposure
on wound-associated gene expression was assessed by quantitative RT-
PCR. *P < 0.05, **P < 0.001.
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proteins (2 and 6 lg/mL). At 24 hours, a 2.4- and 5.7-fold (P¼
0.005) increase in expression of S100A7 compared with the
untreated control was recorded. At 48 hours, the 6-lg/mL dose
of semipurified B. oleronius protein extract induced a 5.1-fold
increase in the expression of S100A7 (P¼ 0.0012). An increase
of S100A7 expression was evident at 72 hours after exposure
to the 2-lg/mL and 6-lg/mL semipurified Bacillus protein
preparations with a 2.3-fold (P ¼ 0.0163) and 3.8-fold (P ¼
0.0103) increase observed for each dose, respectively. A
significant dose-dependent difference between the 2-lg/mL
and 6-lg/mL semipurified Bacillus protein treatments for the
expression of S100A7 was recorded after 24- (P¼ 0.0005), 48-
(P < 0.0001), and 72-hour (P ¼ 0.0002) exposure of corneal
cells (Fig. 5D).
Cytokine Production in hTCEpi Cells Following
Exposure to Bacillus Proteins
Analysis of the production of cytokines by hTCEpi cells
exposed to crude and semipurified B. oleronius proteins (2
lg/mL) for 24 and 72 hours revealed increased production
of IL-6 and IL-8 (Figs. 6A, 6B) but not of IL-1b and TNF-a
(data not presented). There was a statistically significant
increase in the secretion of IL-6 in cells exposed to
semipurified B. oleronius protein preparation at 24 and 72
hours (P < 0.0001 and P ¼ 0.0014, respectively). A
significant increase in IL-6 secretion also was observed in
cells exposed to crude B. oleronius protein preparation at
24 hours (P ¼ 0.0255). The increased production of IL-6
after exposure of the hTCEpi cells to the semipurified B.
oleronius protein (2 lg/mL) compared with the crude B.
oleronius protein (2 lg/mL) was statistically significant at 24
hours (P¼ 0.0034) but not at 72 hours (Fig. 6A). Interleukin-
8 secretion reached the highest level in cells exposed to
crude Bacillus protein preparation at 24 hours (230 pg/mL)
(P ¼ 0.0003). Semipurified B. oleronius protein preparation
also stimulated IL-8 secretion at 24 and 72 hours. The
secretion of IL-8 by corneal cells stimulated by crude B.
oleronius protein preparation (2 lg/mL) compared with that
by corneal cells stimulated by pure B. oleronius protein (2
lg/mL) at 24 hours was statistically significant (P ¼ 0.0485).
At 72 hours of exposure, secretion of IL-8 by cells exposed
to the semipurified B. oleronius protein was deemed to be
significant (P¼ 0.0003) compared with that by cells exposed
to the crude B. oleronius protein (Fig. 6B).
Effect of Bacillus Proteins on Expression of MMP-9
hTCEpi in Cells
Human telomerase-immortalized corneal epithelial cells were
exposed to semipurified B. oleronius proteins (2 lg/mL and 6
lg/mL) for 24, 48, and 72 hours. Cell culture supernatants
were collected, filter-concentrated, and resolved as described,
and Western blots were performed to assess the effect of
Bacillus proteins on the expression of MMP-9. The results
revealed increased expression of MMP-9 in corneal cells
exposed to semipurified B. oleronius proteins at 2 lg/mL
and 6 lg/mL, with a 2.2-fold (P < 0.0001) and 3.5-fold (P ¼
FIGURE 5. Effect of B. oleronius protein preparation on CCL20 and S100A7 expression in hTCEpi cells. The expression of CCL20 and S100A7 by
hTCEpi cells following exposure to semipurified B. oleronius proteins (pure 2 and 6 lg/mL) was assessed by Western blot at 24, 48, and 72 hours
after stimulation (A, C), and the expression of CCL20 and S100A7 was assessed by densitometric analysis (B, D). *P < 0.05, **P < 0.001.
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0.0096) increase, respectively, relative to the control at 24
hours. A 1.5-fold (P¼ 0.0355) and 3.2-fold (P¼ 0.003) increase
of MMP-9 expression was observed at 48 hours, after exposure
to the 2- and 6-lg/mL semipurified B. oleronius protein
preparations, respectively. At 72 hours, MMP-9 expression in
corneal cells treated with 2- and 6-lg/mL semipurified Bacillus
proteins showed a 1.3- and 2.2-fold increase, respectively,
compared with the control. A significant dose-dependent
FIGURE 6. Interleukin-6 and IL-8 secretion by hTCEpi cells exposed to B. oleronius protein preparation. Interleukin-6 and IL-8 secreted by hTCEpi
cells in response to crude (crude 2 lg/mL) and semipurified Bacillus (pure 2 lg/mL) protein preparations were assessed 24 hours and 72 hours
after stimulation by ELISA analysis (A, B). *P < 0.05, **P < 0.01, ***P < 0.001.
FIGURE 7. Matrix metalloproteinase-9 expression in hTCEpi cells exposed to B. oleronius protein preparation. The expression of MMP-9 in
supernatants of hTCEpi cells exposed to semipurified B. oleronius protein preparations (2 and 6 lg/mL) was analyzed through Western blotting 24,
48, and 72 hours after stimulation (A), and MMP-9 expression was assessed by densitometric analysis (B). *P < 0.05, **P < 0.01, ***P < 0.001.
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change in expression of MMP-9 between the 2 lg/mL and 6 lg/
mL semipurified Bacillus protein treatments was not observed
at 24 or 72 hours, but a significant difference in dose-response
was recorded at 48 hours (P ¼ 0.0105) (Fig. 7).
Exposure of Cells to Bacillus Proteins Induces
Increased MMP-9 Activity
Human telomerase-immortalized corneal epithelial cells were
exposed to 2- or 6-lg/mL Bacillus protein preparations for up
to 6 days, and MMP-9 activity was measured as described. The
results revealed a significant dose-dependent increase in MMP-
9 activity over the course of the experiment and a 1.8-fold (P¼
0.0134) and 2.3-fold (P ¼ 0.0215) increase in MMP-9 activity
was shown after stimulation of hTCEpi cells with 2- and 6-lg/
mL semipurified B. oleronius protein after 3 days of exposure.
At day 6, a 1.5-fold increase in MMP-9 activity was recorded
after exposure of hTCEpi cells to the semipurified B. oleronius
protein (2 lg/mL), and a statistically significant increase in
MMP-9 activity was observed in cells exposed to the higher
dose of semipurified B. oleronius protein extract (6 lg/mL) (P
¼ 0.0186); a 2.2-fold increase was observed at day 6 compared
with untreated hTCEpi cells (Fig. 8). Matrix metalloproteinase-
9 plays a role in tissue degradation, but is also a trigger for
neovascularization in vivo. The growth of new blood vessels is
a feature of corneal damage in ocular rosacea.5,6
DISCUSSION
The results presented here demonstrate that exposure of a
corneal epithelial cell line to Bacillus proteins results in a
reduction in cell proliferation and the induction of an
inflammatory response as indicated by the increased expres-
sion of genes coding for IL-6, IL-1b, IL-8, S100A7, and TNF-a,
and elevated MMP-9 production and activity. A dose-response
effect was observed when hTCEpi cells were exposed to
different concentrations of Bacillus protein (i.e., 2 lg/mL and
6 lg/mL), and this effect is particularly evident in changes in
cell proliferation (MGT at day 3; P ¼ 0.0427) (Fig. 1), S100A7
expression (at 24 [P¼ 0.0005], 48 [P < 0.0001], and 72 hours
[P ¼ 0.0002]) (Figs. 5C, 5D), and MMP-9 expression (at 48
hours; P ¼ 0.0105) (Fig. 7). Corneal damage is one of the
features of ocular rosacea and leads to the degradation of the
corneal surface and the formation of sterile ulcers and corneal
scaring.5,6 We previously demonstrated the ability of Bacillus
proteins to induce an aberrant wound-healing response in
cultured hTCEpi cells.21
Exposure of hTCEpi cells to the Bacillus protein prepara-
tion reduced the rate of proliferation and the antiproliferative
effect was demonstrated to be due to G1 phase arrest.
Exposure to the Bacillus proteins did not induce apoptosis,
consequently the reduction in cell proliferation was not due to
increased levels of cell death. The elevated expression of the
cytokines IL-1b, IL-6, IL-8, and TNF-a has been shown in a
number of inflammatory cornea pathologies.30,31 The elevation
of these cytokines results in angiogenesis, inflammation, and
sterile ulcer formation due to their upregulation of MMP-9.31–33
However, a recent study demonstrated no increase in these
cytokines in the tear fluid of rosacea patients and an
upregulation of these cytokines in ocular rosacea patients
was not observed.34 The lack of expression may be due to the
ocular rosacea patients possessing only mild symptoms and
thus alterations in expression were too low to be detected.
Chemokine ligand-20/MIP-3a is similar functionally to the b-
defensins in its role as an antibacterial agent and the
recruitment of cells into the cornea after wounding.35–37 It
has been shown to be upregulated by the cytokines IL-1b and
TNF-a in cornea.38
The exposure of hTCEpi cells to Bacillus proteins induced
the increased expression and activity of MMP-9. Matrix
metalloproteinase-9 is expressed during cell migration and
matrix remodeling in cornea wound repair by the cornea
FIGURE 8. Matrix metalloproteinase-9 activity in hTCEpi cells exposed to B. oleronius protein preparation. Increased enzymatic activity of MMP-9
in hTCEpi cells exposed to semipurified B. oleronius proteins (2 and 6 lg/mL), 3 days and 6 days after stimulation was observed compared with the
untreated control (A). Densitometry was calculated using ImageJ software and images from corresponding zymograms show that activity of MMP-9
increases after stimulation of hTCEpi cells to the B. oleronius protein extracts, and a significant increase of MMP-9 activity was recorded at day 6
after exposure to the higher concentration of protein (6 lg/mL) (P ¼ 0.0186) (B). *P < 0.05.
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epithelium.39 It also controls timing of inflammation response
around cornea repair.40 However, its expression is finely
balanced and elevated levels of MMP-9 have been demonstrat-
ed to have a negative role in epithelial cell replication and
barrier function in the cornea.41 In this context, elevation of
MMP-9 has been linked to a number of corneal pathologies,
including sterile ulcer formation and ocular rosacea.42–44 The
results presented here show the effect of Bacillus proteins on
transformed corneal cells over a short time frame and
demonstrate that the increased expression and activity of
MMP-9 corresponds with an increased mean generation time
and decreased corneal cell proliferation at day 3, a G1/S
transition block in the cell cycle at day 2, increased expression
of S100A7 and CCL20/MIP-3a, and increased production of IL-6
and IL-8.
Elevated densities of Demodex mites on the eyelashes are a
feature of ocular rosacea,5,6 but their role in the etiology of the
condition is unclear.7,10,11 We have previously demonstrated a
positive correlation between serum reactivity to Bacillus
proteins and ocular rosacea, thus suggesting a role for this
bacterium in the condition.12 One possible scenario linking the
elevated density of Demodex mites and the induction of
corneal damage involves the release of bacterial cells/antigens
from dead Demodex mites on the eyelashes. These may fall
onto the corneal surface and induce an aberrant wound-healing
response.21 In addition, the results presented here indicate the
induction of an inflammatory response that would contribute
to the degradation of corneal tissue and the induction of sterile
ulcers or scarring in vivo. Understanding the interaction of
Demodex-associated Bacillus proteins with the corneal surface
may aid in the design of specific therapies to reduce the
severity of symptoms arising from this interaction.
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